Search
for
Sort by
Research 751–780 of 1000+
- Telogen effluvium in the new SARS‐CoV‐2 era
- Telogen effluvium and COVID-19: a cross-sectional study.
- Pediatric alopecia areata following COVID‐19 infection
- [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- A scoping review of alopecia areata and its relationship to COVID-19 vaccinations
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Impacts of COVID-19 Pandemic on Dermatology Outpatient Department at a Tertiary Hospital in Eastern China: A Pre-Post Study
- Androgen sensitivity gateway to COVID‐19 disease severity
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
- Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic
- A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- New Onset of Hair Loss Disorders During the Coronavirus Disease 2019 Pandemic: A Korean Nationwide Population-Based Study
- Anais do II Congresso Nacional Acadêmico de Dermatologia
- Systematic characterization of the barrier function of diverse ex vivo models of damaged human skin
- Equine Hoof Stem Progenitor Cells (HPC) CD29 + /Nestin + /K15 + – a Novel Dermal/epidermal Stem Cell Population With a Potential Critical Role for Laminitis Treatment
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Tissue Resident Foxp3+ Regulatory T Cells: Sentinels and Saboteurs in Health and Disease
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- COVID‐19, androgens, and androgenic alopecia
- Therapy experience in alopecia after COVID-19
- Evaluating the Difference Between COVID-19-Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes
- Black dots in trichoscopy after COVID‐19. Can it be telogen effluvium?
- Análise da qualidade de vida em indivíduos com alopecia pós-COVID-19
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy